The injectable version is taken once per week and is FDA-approved for adults with type 2 diabetes to: Improve blood sugar when combined with diet and exercise Reduce the risk of heart attack, stroke, or cardiovascular death in adults who also have known heart disease Reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults who also have chronic kidney disease
Ethics approval All procedures followed were in accordance with the international standards of animal protection and the ethical principles of the National Council of Animal Experimentation and was approved by the Ethics Committee on Animal Use of the University Federal of Ouro Preto (#2014/17)
"Recognizing the challenges GLP-1 users face, protein in particular plays a critical role
Watch for signs of dehydration: dark urine, dry mouth, dizziness, or fatigue
Keep a simple list for your provider and communicate side effects promptly